Company Overview and News

79
Triple-S Management (GTS) Soared to a 52-Week-High, Time to Cash Out?

2018-06-21 zacks
Have you been paying attention to shares of Triple-S Management (GTS - Free Report) ? Shares have been on the move, with the stock up 14.7% over the past month. GTS hit a new 52-week-high of $41.92 in the previous session. Triple-S Management has gained 67.9% since the start of the year compared to the 2.3% move for the Medical sector and the 13.7% year-to-date return for its peer group.
CECO MS.PRE WCG MS.PRF MS.PRG ANTM HUM MS.PRA MS.PRI AMCX GTS MS.PRK MS BRKS

94
Intuit (INTU) Soared to a 52-Week-High, Time to Cash Out?

2018-06-21 zacks
Have you been paying attention to shares of Intuit (INTU - Free Report) ? Shares have been on the move, with the stock up 8.8% over the past month. INTU hit a new 52-week-high of $213.76 in the previous session. Intuit has gained 35.3% since the start of the year compared to the 9.3% move for the Computer and Technology sector and the 17.4% year-to-date return for its peer group.
VRNT SAPGF CECO MS.PRE MS.PRF MS.PRG MS.PRA ADBE SAP INTU MS.PRI AMCX MS.PRK MS BRKS

84
Zacks.com featured highlights include: General Motors, Boston Scientific, Antero NRG, AMC and Celanese

2018-06-19 zacks
Chicago, IL – June 19, 2018 - Stocks in this week’s article General Motors Company (GM - Free Report) , Boston Scientific Corp. (BSX - Free Report) , Antero NRG Energy, Inc. (NRG - Free Report) , AMC Networks Inc. (AMCX - Free Report) and Celanese Corp. (CE - Free Report) .
HD RCKY NRG BSX AMCX GM.WS.A GM.WS.B GM.WS.C GM PKD GM.WSB CE

98
Box Office Top 20: 'Incredibes 2' record inches higher

2018-06-18 nzherald.co.nz
LOS ANGELES (AP) — Disney and Pixar's record-breaking opening of "Incredibles 2" is even bigger than initially expected. According to final totals Monday from the studios, the animated sequel grossed a massive $182.7 million in its first three days in theaters — a record opening for animated movies by almost $50 million.
VIA LGF CCV CMCSA TWX CCZ SNEJF TWC AMCX VIAB CCV.CL LGF.A SNE LGF.B CMCSK DIS

349
Will AT&T/Time Warner Ruling Accelerate M&A?

2018-06-18 seekingalpha
The market’s positive reaction to the AT&T/Time Warner decision paves the way for other vertical deals.
FB S AMCX DBS CMCSA TWX AAPL NFLX CI TWC AET

21
AMCX vs. NFLX: Which Stock Is the Better Value Option?

2018-06-18 zacks
Investors interested in stocks from the Broadcast Radio and Television sector have probably already heard of AMC Networks (AMCX - Free Report) and Netflix (NFLX - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
AMCX NFLX

73
Top 5 ROE Stocks to Buy as Trump Keeps Trade War Fears Alive

2018-06-18 zacks
The on-again off-again trade war between the United States and China took a new turn when President Trump imposed a fresh salvo of tariffs worth $50 billion on Chinese imports last week. This followed an immediate retaliation by China, which promised to match the scale of the trade restrictions on a vast array of U.S. goods. The flurry of events caused a mild slide in most of the benchmark indices as tensions brewed among the investor community.
NRGEO NRG BSX AMCX GM.WS.A GM.WS.B ENSG GM.WS.C GM GM.WSB CE

15
AMCX / AMC Networks Inc. 8-K (Current Report)

2018-06-14 sec.gov
Document UNITED STATES
AMCX

44
Dolby (DLB) Eyes Expansion in Europe, Clinches Dual Deals

2018-06-14 zacks
In the 2018 CineEurope trade show, Dolby Laboratories, Inc. (DLB - Free Report) announced its plans to expand operations into the European cinema market. In addition to this, the company also advertised its non-imitable imaging, audio, post-production and accessibility technology in the expo. In sync with the aforementioned plan, Dolby Laboratories has inked an agreement with Odeon Cinemas Group — an acquired business arm of AMC Entertainment Holdings, Inc.
APEI AMC AMCX DLB

248
With or Without Time Warner, AT&T Stock Isn't Worth Buying | InvestorPlace

2018-06-13 investorplace
The acquisition of Time Warner Inc (NYSE:TWX) by AT&T Inc. (NYSE:T) appears to be a go. And the approval of the AT&T-TWX merger, announced Tuesday afternoon, already is reverberating through the market.
DISCB DISCA CCV TWX CCZ DISCK AMCX VIAB AET CMCSK DIS DISC CBS VIA FOX TMUSP CBS.A TMUS CMCSA TWC CBS.WD S T CCV.CL CPV FOXA ESRX

21
John Wiley & Sons (JW.A) Tops Q4 Earnings, Revenue Estimates

2018-06-13 zacks
John Wiley & Sons, Inc. (JW.A - Free Report) posted better-than-expected results in the fourth quarter of fiscal 2018, wherein both the top and the bottom line surpassed the Zacks Consensus Estimate. While earnings beat estimates for the seventh consecutive quarter, sales recorded the fifth straight beat.
AMCX XOM ROKU

15
AMCX / AMC Networks Inc. 8-K (Current Report)

2018-06-13 sec.gov
Document UNITED STATES
AMCX

16
AMC Networks Inc. Announces $500 Million Increase in Stock Repurchase Program

2018-06-13 globenewswire
NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ:AMCX) today announced that its board of directors has approved an increase of $500 million to its previously announced program to repurchase its outstanding shares of common stock. The new authorization of $500 million increases the total amount authorized to $1.5 billion under the stock repurchase program.
AMCX

15
Is AMC Networks (AMCX) a Great Stock for Value Investors?

2018-06-07 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
AMCX

21
Daqo New Energy (DQ) Enters Oversold Territory

2018-06-07 zacks
Daqo New Energy Corp. (DQ - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at DQ given that, according to its RSI reading of 26.94, it is now in oversold territory.
ODT TTMI DQ AMCX CECO

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to AMCX / AMC Networks Inc. on message board site Silicon Investor.

AMCX - AMERICLEAN, INC.
CUSIP: 00164V103